Winter Olympics: Kamila Valieva sample 'showed three drugs'

Kamila Valieva's anti-doping sample showed traces of three drugs that can be used to treat heart conditions, according to a New York Times report.

The 15-year-old Russian figure skater is being allowed to compete at Beijing 2022 despite testing positive for banned angina drug trimetazidine.

The report said it also showed hyproxen and L-Carnitine, which are not banned.

The combination of substances prompted «a lot of red flags», United States anti-doping chief Travis Tygart said.

«Those are three substances that are all used for increasing performance,» he told BBC sports editor Dan Roan on the Sports Desk Podcast, explaining they can increase endurance and reduce fatigue.

The case is ongoing and Valieva has the right to request the testing of her B sample, under World Anti-Doping Agency (Wada) rules.

She goes into Thursday's free skate top of the standings and on track for victory — but if she finished in the top three, there will be no medal or ceremony until her anti-doping case has been concluded.

The medals for the team event, where she helped the Russian Olympic Committee to victory before learning of the failed test, are also on hold for the same reason.

The International Olympic Committee (IOC) said on Tuesday that Valieva has argued her positive drugs test was due to contamination with her grandad's medicine.

Neither the IOC nor Russian Olympic Committee has commented on the report that the Stockholm laboratory that processed the sample had found evidence of three drugs.

In its report, the New York Times cited documents filed in Valieva's arbitration hearing this week and confirmed by someone who took part in the hearing.

Valieva was allowed to continue competing at the Games after the Court of Arbitration for Sport (Cas)